STUDY SNAPSHOT
Who or what was studied?
Adults undergoing bowel-resection surgery.
What was measured?
Time to tolerance of a standardized solid meal.
What the selected report found
A phase 2 placebo-controlled study of intravenous ipamorelin did not show a statistically significant difference in its key efficacy endpoint.
The surgical setting and intravenous formulation do not establish effects for general fitness, recovery or a retail blend.
A numerical difference needs statistical context
Two groups can have different observed averages without the study demonstrating a reliable treatment effect. Read the planned endpoint and analysis before deciding what the difference means. A result should be carried forward with its uncertainty and original clinical context.
Source trail
Beck et al. · International Journal of Colorectal Disease · 2014
This is a selected-source reading brief, not a comprehensive literature review, product verification or recommendation to use a compound.